{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:25:27Z","timestamp":1773285927599,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2012,8,26]],"date-time":"2012-08-26T00:00:00Z","timestamp":1345939200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunogenetics"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s00251-012-0648-7","type":"journal-article","created":{"date-parts":[[2012,8,25]],"date-time":"2012-08-25T08:05:40Z","timestamp":1345881940000},"page":"879-885","source":"Crossref","is-referenced-by-count":12,"title":["The impact of HLA-C matching depends on the C1\/C2 KIR ligand status in unrelated hematopoietic stem cell transplantation"],"prefix":"10.1007","volume":"64","author":[{"given":"Johannes C.","family":"Fischer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Kobbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Enczmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Haas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Uhrberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,26]]},"reference":[{"issue":"2","key":"648_CR1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.immuni.2006.06.013","volume":"25","author":"N Anfossi","year":"2006","unstructured":"Anfossi N, Andre P, Guia S, Falk CS, Roetynck S, Stewart CA, Breso V, Frassati C, Reviron D, Middleton D, Romagne F, Ugolini S, Vivier E (2006) Human NK cell education by inhibitory receptors for MHC class I. Immunity 25(2):331\u2013342","journal-title":"Immunity"},{"issue":"14","key":"648_CR2","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1182\/blood-2010-05-283051","volume":"116","author":"S Cooley","year":"2010","unstructured":"Cooley S, Weisdorf DJ, Guethlein LA, Klein JP, Wang T, Le CT, Marsh SG, Geraghty D, Spellman S, Haagenson MD, Ladner M, Trachtenberg E, Parham P, Miller JS (2010) Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. Blood 116(14):2411\u20132419","journal-title":"Blood"},{"issue":"4","key":"648_CR3","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1055\/s-2008-1043792","volume":"211","author":"J Enczmann","year":"1999","unstructured":"Enczmann J, Rinker M, Kiesel U, Kuhrober A, Kogler G, Nurnberger W, Gobel U, Wernet P (1999) Donor selection process for allogeneic hematopoietic stem cell transplantation at the university hospital of Dusseldorf (1997\u20131998). Klin Padiatr 211(4):218\u2013223","journal-title":"Klin Padiatr"},{"key":"648_CR4","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496\u2013509","journal-title":"J Am Stat Assoc"},{"issue":"6","key":"648_CR5","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.4049\/jimmunol.178.6.3918","volume":"178","author":"JC Fischer","year":"2007","unstructured":"Fischer JC, Ottinger H, Ferencik S, Sribar M, Punzel M, Beelen DW, Schwan MA, Grosse-Wilde H, Wernet P, Uhrberg M (2007) Relevance of C1 and C2 epitopes for hemopoietic stem cell transplantation: role for sequential acquisition of HLA-C-specific inhibitory killer Ig-like receptor. J Immunol 178(6):3918\u20133923","journal-title":"J Immunol"},{"issue":"7","key":"648_CR6","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1182\/blood-2004-03-0803","volume":"104","author":"N Flomenberg","year":"2004","unstructured":"Flomenberg N, Baxter-Lowe LA, Confer D, Fernandez-Vina M, Filipovich A, Horowitz M, Hurley C, Kollman C, Anasetti C, Noreen H, Begovich A, Hildebrand W, Petersdorf E, Schmeckpeper B, Setterholm M, Trachtenberg E, Williams T, Yunis E, Weisdorf D (2004) Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 104(7):1923\u20131930","journal-title":"Blood"},{"issue":"4","key":"648_CR7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2141.2005.05797.x","volume":"131","author":"S Giebel","year":"2005","unstructured":"Giebel S, Locatelli F, Wojnar J, Velardi A, Mina T, Giorgiani G, Krawczyk-Kulis M, Markiewicz M, Wylezol I, Holowiecki J (2005) Homozygosity for human leucocyte antigen-C ligands of KIR2DL1 is associated with increased risk of relapse after human leucocyte antigen-C-matched unrelated donor haematopoietic stem cell transplantation. Br J Haematol 131(4):483\u2013486","journal-title":"Br J Haematol"},{"issue":"4","key":"648_CR8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, Lerner KG, Thomas ED (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18(4):295\u2013304","journal-title":"Transplantation"},{"issue":"11","key":"648_CR9","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1084\/jem.20091010","volume":"206","author":"T Graef","year":"2009","unstructured":"Graef T, Moesta AK, Norman PJ, Abi-Rached L, Vago L, Older Aguilar AM, Gleimer M, Hammond JA, Guethlein LA, Bushnell DA, Robinson PJ, Parham P (2009) KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C. J Exp Med 206(11):2557\u20132572","journal-title":"J Exp Med"},{"issue":"8","key":"648_CR10","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.bbmt.2006.04.008","volume":"12","author":"KC Hsu","year":"2006","unstructured":"Hsu KC, Gooley T, Malkki M, Pinto-Agnello C, Dupont B, Bignon JD, Bornhauser M, Christiansen F, Gratwohl A, Morishima Y, Oudshoorn M, Ringden O, van Rood JJ, Petersdorf E (2006) KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy. Biology of blood and marrow transplantation 12(8):828\u2013836","journal-title":"Biology of blood and marrow transplantation"},{"issue":"7051","key":"648_CR11","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nature03847","volume":"436","author":"S Kim","year":"2005","unstructured":"Kim S, Poursine-Laurent J, Truscott SM, Lybarger L, Song YJ, Yang L, French AR, Sunwoo JB, Lemieux S, Hansen TH, Yokoyama WM (2005) Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436(7051):709\u2013713","journal-title":"Nature"},{"issue":"6","key":"648_CR12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0198-8859(00)00114-2","volume":"61","author":"AJ Knipper","year":"2000","unstructured":"Knipper AJ, Hakenberg P, Enczmann J, Kuhrober A, Kiesel U, Kogler G, Wernet P (2000) HLA-DRB1,3,4,5 and -DQB1 allele frequencies and HLA-DR\/DQ linkage disequilibrium of 231 German caucasoid patients and their corresponding 821 potential unrelated stem cell transplants. Hum Immunol 61(6):605\u2013614","journal-title":"Hum Immunol"},{"issue":"1","key":"648_CR13","doi-asserted-by":"crossref","first-page":"644","DOI":"10.4049\/jimmunol.172.1.644","volume":"172","author":"W Leung","year":"2004","unstructured":"Leung W, Iyengar R, Turner V, Lang P, Bader P, Conn P, Niethammer D, Handgretinger R (2004) Determinants of antileukemia effects of allogeneic NK cells. J Immunol 172(1):644\u2013650","journal-title":"J Immunol"},{"issue":"7","key":"648_CR14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0167-5699(90)90097-S","volume":"11","author":"HG Ljunggren","year":"1990","unstructured":"Ljunggren HG, Karre K (1990) In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 11(7):237\u2013244","journal-title":"Immunol Today"},{"issue":"10","key":"648_CR15","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1038\/leu.2011.123","volume":"25","author":"T Lodewyck","year":"2011","unstructured":"Lodewyck T, Oudshoorn M, van der Holt B, Petersen E, Spierings E, von dem Borne PA, Schattenberg A, Allebes W, Groenendijk-Sijnke M, Duinhouwer L, Willemze R, Lowenberg B, Verdonck LF, Meijer E, Cornelissen JJ (2011) Predictive impact of allele-matching and EBMT risk score for outcome after T-cell depleted unrelated donor transplantation in poor-risk acute leukemia and myelodysplasia. Leukemia 25(10):1548\u20131554","journal-title":"Leukemia"},{"issue":"11","key":"648_CR16","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1182\/blood.V99.11.4200","volume":"99","author":"Y Morishima","year":"2002","unstructured":"Morishima Y, Sasazuki T, Inoko H, Juji T, Akaza T, Yamamoto K, Ishikawa Y, Kato S, Sao H, Sakamaki H, Kawa K, Hamajima N, Asano S, Kodera Y (2002) The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. Blood 99(11):4200\u20134206","journal-title":"Blood"},{"issue":"9","key":"648_CR17","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1182\/blood-2004-04-1674","volume":"104","author":"EW Petersdorf","year":"2004","unstructured":"Petersdorf EW, Anasetti C, Martin PJ, Gooley T, Radich J, Malkki M, Woolfrey A, Smith A, Mickelson E, Hansen JA (2004) Limits of HLA mismatching in unrelated hematopoietic cell transplantation. Blood 104(9):2976\u20132980","journal-title":"Blood"},{"issue":"5562","key":"648_CR18","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","volume":"295","author":"L Ruggeri","year":"2002","unstructured":"Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, Posati S, Rogaia D, Frassoni F, Aversa F, Martelli MF, Velardi A (2002) Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295(5562):2097\u20132100","journal-title":"Science"},{"issue":"2","key":"648_CR19","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","volume":"69","author":"HM Shulman","year":"1980","unstructured":"Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, Hackman R, Tsoi MS, Storb R, Thomas ED (1980) Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 69(2):204\u2013217","journal-title":"Am J Med"},{"issue":"6","key":"648_CR20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1083-8791(99)70010-8","volume":"5","author":"ED Thomas","year":"1999","unstructured":"Thomas ED, Blume KG (1999) Historical markers in the development of allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 5(6):341\u2013346","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"648_CR21","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1074-7613(00)80394-5","volume":"7","author":"M Uhrberg","year":"1997","unstructured":"Uhrberg M, Valiante NM, Shum BP, Shilling HG, Lienert-Weidenbach K, Corliss B, Tyan D, Lanier LL, Parham P (1997) Human diversity in killer cell inhibitory receptor genes. Immunity 7(6):753\u2013763","journal-title":"Immunity"},{"issue":"4","key":"648_CR22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00251-002-0463-7","volume":"54","author":"M Uhrberg","year":"2002","unstructured":"Uhrberg M, Parham P, Wernet P (2002) Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes. Immunogenetics 54(4):221\u2013229","journal-title":"Immunogenetics"},{"issue":"5","key":"648_CR23","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.4049\/jimmunol.0804042","volume":"182","author":"J Bergen van","year":"2009","unstructured":"van Bergen J, Thompson A, Retiere C, Trowsdale J, Koning F (2009) Cutting edge: killer Ig-like receptors mediate \"missing self\" recognition in vivo. J Immunol 182(5):2569\u20132572","journal-title":"J Immunol"},{"issue":"5","key":"648_CR24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.coi.2008.07.004","volume":"20","author":"A Velardi","year":"2008","unstructured":"Velardi A (2008) Role of KIRs and KIR ligands in hematopoietic transplantation. Curr Opin Immunol 20(5):581\u2013587","journal-title":"Curr Opin Immunol"},{"issue":"6","key":"648_CR25","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00262-008-0601-7","volume":"58","author":"S Verheyden","year":"2009","unstructured":"Verheyden S, Ferrone S, Mulder A, Claas FH, Schots R, De Moerloose B, Benoit Y, Demanet C (2009) Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells. Cancer Immunol Immunother 58(6):855\u2013865","journal-title":"Cancer Immunol Immunother"},{"issue":"6","key":"648_CR26","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.bbmt.2010.09.012","volume":"17","author":"A Woolfrey","year":"2011","unstructured":"Woolfrey A, Klein JP, Haagenson M, Spellman S, Petersdorf E, Oudshoorn M, Gajewski J, Hale GA, Horan J, Battiwalla M, Marino SR, Setterholm M, Ringden O, Hurley C, Flomenberg N, Anasetti C, Fernandez-Vina M, Lee SJ (2011) HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation. Biology of blood and marrow transplantation 17(6):885\u2013892","journal-title":"Biology of blood and marrow transplantation"}],"container-title":["Immunogenetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00251-012-0648-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00251-012-0648-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00251-012-0648-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T15:03:04Z","timestamp":1558710184000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00251-012-0648-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,26]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["648"],"URL":"https:\/\/doi.org\/10.1007\/s00251-012-0648-7","relation":{},"ISSN":["0093-7711","1432-1211"],"issn-type":[{"value":"0093-7711","type":"print"},{"value":"1432-1211","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,26]]}}}